Not applicableStudy completedNCT00969891What this trial is testingStudy of Dosage Individualisation for the Treatment of Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Mikkel Krogh-Madsen 23
Not applicableEnded earlyNCT00513318What this trial is testingPilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more University of California, San Francisco 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06858618What this trial is testingFCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid NeoplasmsWho this might be right forSafetyAntitumor ActivityPK Profile Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT00797758What this trial is testingReduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Assistance Publique - Hôpitaux de Paris 76
Large-scale testing (Phase 3)Looking for participantsNCT05726110What this trial is testingSelinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed or Refractory Acute Myeloid Leukemia Shanxi Bethune Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00065143What this trial is testingClofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeWho this might be right forLeukemia, MyeloidMyelodysplastic Syndromes M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00136084What this trial is testingTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or MyelodysplasiaWho this might be right forLeukemia, Myelocytic, Acute St. Jude Children's Research Hospital 238
Early research (Phase 1)Looking for participantsNCT07020533What this trial is testingA Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more City of Hope Medical Center 46
Testing effectiveness (Phase 2)Ended earlyNCT01573247What this trial is testingSafety Study of AKN-028 in Patients With Acute Myelogenous LeukemiaWho this might be right forAcute Myeloid Leukemia Akinion Pharmaceuticals AB 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980885What this trial is testingA Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Akeso 68
Early research (Phase 1)Study completedNCT05470140What this trial is testingWU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Allotera Therapeutics 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT01885689What this trial is testingClofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic LeukemiaWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in Remission+4 more City of Hope Medical Center
Early research (Phase 1)Study completedNCT02485535What this trial is testingSelinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After TransplantWho this might be right forAcute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more University of Chicago 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07562568What this trial is testingSHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDSWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more The First Affiliated Hospital of Soochow University 160
Testing effectiveness (Phase 2)Study completedNCT01643668What this trial is testingBusulfan/Clofarabine + Allogeneic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Ended earlyNCT06679582What this trial is testingLuveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLWho this might be right forAcute Myeloid Leukemia (AML) Sutro Biopharma, Inc. 24
Early research (Phase 1)Study completedNCT00402558What this trial is testingAlloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)Who this might be right forMyelodysplastic SyndromeLeukemia M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT07471789What this trial is testingSafety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).Who this might be right forAcute Myeloblastic LeukaemiaLeukemia, T-Cell Gyala Therapeutics 33
Testing effectiveness (Phase 2)WithdrawnNCT03187691What this trial is testingSafety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic LeukaemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Matinas BioPharma Nanotechnologies, Inc.
Early research (Phase 1)Ended earlyNCT03360006What this trial is testingA Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) CancerWho this might be right forAcute Myeloid Leukemia (AML) AbbVie 30